spironolactone has been researched along with dutasteride in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bandaranayake, I; Mirmirani, P | 1 |
| Ioannides, D; Lazaridou, E | 1 |
| Clark, AK; Quinonez, RL; Saric, S; Sivamani, RK | 1 |
| Azarchi, S; Bienenfeld, A; Lo Sicco, K; Marchbein, S; Nagler, AR; Shapiro, J | 1 |
| Cadegiani, FA; Comeche, B; Gioia, F; Goren, A; Herrera, S; Kovacevic, M; McCoy, J; Ramos, PM; Ron, R; Serrano-Villar, S; Shapiro, J; Sinclair, R; Tosti, A; Vaño-Galván, S; Wambier, CG | 1 |
5 review(s) available for spironolactone and dutasteride
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Hair loss remedies--separating fact from fiction.
Topics: Alopecia; Azasteroids; Dietary Supplements; Dutasteride; Enzyme Inhibitors; Female; Finasteride; Humans; Low-Level Light Therapy; Male; Mineralocorticoid Receptor Antagonists; Minoxidil; Spironolactone; Treatment Outcome; Vasodilator Agents | 2004 |
Female pattern hair loss.
Topics: 5-alpha Reductase Inhibitors; Administration, Cutaneous; Alopecia; Androgen Antagonists; Androgen Receptor Antagonists; Antifungal Agents; Cyproterone Acetate; Dutasteride; Female; Finasteride; Flutamide; Hair; Humans; Ketoconazole; Minoxidil; Postmenopause; Spironolactone; Vasodilator Agents | 2015 |
Hormonal therapies for hidradenitis suppurativa: Review.
Topics: 5-alpha Reductase Inhibitors; Contraceptives, Oral, Hormonal; Dutasteride; Female; Finasteride; Hidradenitis Suppurativa; Hormones; Humans; Male; Spironolactone | 2017 |
Androgens in women: Hormone-modulating therapies for skin disease.
Topics: 5-alpha Reductase Inhibitors; Acne Vulgaris; Adrenal Hyperplasia, Congenital; Alopecia; Androgen Antagonists; Androgens; Contraceptives, Oral, Combined; Dutasteride; Female; Finasteride; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Receptors, Androgen; Spironolactone | 2019 |
2 other study(ies) available for spironolactone and dutasteride
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; COVID-19; Dutasteride; Finasteride; Humans; Intensive Care Units; Male; Middle Aged; Observational Studies as Topic; Patient Admission; Prospective Studies; SARS-CoV-2; Spironolactone | 2021 |